The Week in Review: Oct 23 – Oct 28, 2016
Friday, October-28-16
News in Brief
Restricted Reimbursement for DAAs Hinders Progress Towards Global Hepatitis C Eradication Goal
October 27, 2016
There are significant differences in the criteria for reimbursing for direct-acting antivirals (DAAs) for patients with hepatitis C virus (HCV) among the provinces in Canada, according to the results of a recent study. Conducted by Alison Marshall, MA, of The Kirby Institute, and colleagues, the study...